tiprankstipranks
Trending News
More News >
Daito Pharmaceutical Co., Ltd. (JP:4577)
:4577
Japanese Market

Daito Pharmaceutical Co., Ltd. (4577) Income Statement

Compare
0 Followers

Daito Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q1 2025), Daito Pharmaceutical Co., Ltd.'s total revenue was ¥13.01B, an increase of 2.63% from the same quarter last year. In Q1, Daito Pharmaceutical Co., Ltd.'s net income was ¥696.00M. See Daito Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 50.64B¥ 46.90B¥ 45.10B¥ 43.46B¥ 48.71B
Gross Profit
¥ 8.64B¥ 9.84B¥ 10.33B¥ 11.46B¥ 10.79B
Operating Expenses
¥ 6.02B¥ 5.95B¥ 5.12B¥ 4.91B¥ 4.88B
Depreciation and Amortization
¥ 4.33B¥ 3.66B¥ 3.87B¥ 3.31B¥ 3.15B
EBITDA
¥ 7.41B¥ 7.92B¥ 8.96B¥ 9.88B¥ 9.04B
Operating Income
¥ 2.62B¥ 3.89B¥ 5.21B¥ 6.55B¥ 5.91B
Other Income/Expenses
¥ 337.00M¥ 324.00M¥ -130.00M¥ 167.00M¥ -35.00M
Pretax Income
¥ 2.96B¥ 4.22B¥ 5.08B¥ 6.72B¥ 5.87B
Net Income
¥ 1.91B¥ 3.29B¥ 3.60B¥ 4.67B¥ 4.25B
Per Share Metrics
Basic EPS
¥ 62.72¥ 105.00¥ 113.82¥ 152.45¥ 141.36
Diluted EPS
¥ 62.72¥ 105.00¥ 113.71¥ 152.45¥ 141.36
Weighted Average Shares Outstanding
30.42M 15.69M 15.81M 15.31M 15.02M
Weighted Average Shares Outstanding (Diluted)
30.42M 15.69M 15.83M 15.31M 15.02M
Currency in JPY

Daito Pharmaceutical Co., Ltd. Earnings and Revenue History